Results 41 to 50 of about 82,737 (218)

Therapeutic decision making in autoimmune and inflammatory disorders of the central nervous system in children. [PDF]

, 2016
Autoimmune and inflammatory disorders of the central nervous system can result in significant morbidity and mortality. Through the recognition of syndromes using diagnostic biomarkers, the clinician is now able to use immune suppressive therapies to ...
Dale, Rc, Lim, M., Nosadini, M
core   +3 more sources

Clinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation

Frontiers in Neurology, 2021
Background: The clinical spectrum of coronavirus disease 2019 (COVID-19), due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, may be quite wide, including neurological symptoms.
Micol Avenali, Micol Avenali, Daniele Martinelli, Daniele Martinelli, Massimiliano Todisco, Massimiliano Todisco, Isabella Canavero, Francesca Valentino, Giuseppe Micieli, Enrico Alfonsi, Cristina Tassorelli, Cristina Tassorelli, Giuseppe Cosentino, Giuseppe Cosentino   +13 more
doaj   +1 more source

Hospital discharges-based search of acute flaccid paralysis cases 2007-2016 in Italy and comparison with the National Surveillance System for monitoring the risk of polio reintroduction [PDF]

, 2019
Background: Acute flaccid paralysis (AFP) surveillance has been adopted globally as a key strategy for monitoring the progress of the polio eradication initiative.
Affanni P., Amato C., Ansaldi F., Arghittu A., Bellino S., Binda S., Bonaccorsi G., Brusaferro S., Buttinelli G., Camilloni B., Capannolo B., Carraro V., Castiglia P., D'errico M.M., De Grazia S., De Stefano C., Fiore S., Foca A., Fontana S., Germinario C., Giammanco G., Grasso G.M., Larocca A., Lombardi D., Lorini C., Mancini C., Napoletano G., Pellegrinelli L., Pennino F., Russo F., Spertini S., Stefanelli P., Triassi M., Vairo F., Veronesi L., Zanella F.   +35 more
core   +5 more sources

Effects of the Positive Threshold and Data Analysis on Human MOG Antibody Detection by Live Flow Cytometry

Frontiers in Immunology, 2020
Human autoantibodies targeting myelin oligodendrocyte glycoprotein (MOG Ab) have become a useful clinical biomarker for the diagnosis of a spectrum of inflammatory demyelinating disorders.
Fiona Tea, Fiona Tea, Deepti Pilli, Deepti Pilli, Sudarshini Ramanathan, Sudarshini Ramanathan, Joseph A. Lopez, Joseph A. Lopez, Vera Merheb, Fiona X. Z. Lee, Alicia Zou, Alicia Zou, Ganesha Liyanage, Chelsea B. Bassett, Selina Thomsen, Stephen W. Reddel, Stephen W. Reddel, Michael H. Barnett, David A. Brown, Russell C. Dale, Russell C. Dale, Russell C. Dale, Fabienne Brilot, Fabienne Brilot, Fabienne Brilot, Fabienne Brilot, Australasian New Zealand MOG Study Group   +26 more
doaj   +1 more source

Recurrent longitudinally extensive transversal myelitis in a patient with Sjögren’s syndrome [PDF]

, 2013
Introduction. Longitudinally extensive transverse myelitis (LETM) is a transversal myelitis that extends through three or more vertebral segments in length. Case report.
Gvozdenović Slobodan, Jovin Zita, Kokai-Zekić Timea, Lučić-Prokin Aleksandra, Petrović Kosta, Turkalj Ivan, Šekarić Jelena, Živanović Željko   +7 more
core   +1 more source

Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley   +1 more source

Acute flaccid paralysis with anterior myelitis - California, June 2012-June 2014. [PDF]

, 2014
In August 2012, the California Department of Public Health (CDPH) was contacted by a San Francisco Bay area clinician who requested poliovirus testing for an unvaccinated man aged 29 years with acute flaccid paralysis (AFP) associated with anterior ...
Ayscue, Patrick, Centers for Disease Control and Prevention (CDC), Clayton, Anna, Feikin, Daniel, Glaser, Carol, Harriman, Kathleen, Nix, William Allan, Padilla, Tasha, Pan, Chao, Reichel, John, Sejvar, James, Sheriff, Heather, Van Haren, Keith, Waldron, Paul, Watt, James, Waubant, Emmanuelle, Yagi, Shigeo, Yen, Cynthia   +17 more
core   +1 more source

Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder. [PDF]

, 2016
OBJECTIVE: To study rituximab in pediatric neuromyelitis optica (NMO)/NMO spectrum disorders (NMOSD) and the relationship between rituximab, B cell repopulation, and relapses in order to improve rituximab monitoring and redosing.
Alper, G, Appleton, R, Banwell, B, Benson, La, Brilot, F, Dale, R. C., Deiva, K, Gorman, Mp, Leventer, Rj, Mohammad, Ss, Nolan, M, Nosadini, M, Ramanathan, S, Riney, Cj, Waldman, At   +14 more
core   +1 more source

Spinal Cord Infarction Versus Idiopathic Transverse Myelitis: Clinical, Radiological, and Functional Insights From a Retrospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Spinal cord infarction (SCI) is a rare but devastating myelopathy, characterized by a high disability rate and an unfavorable prognosis. It has often been underdiagnosed and misdiagnosed as idiopathic transverse myelitis (ITM). This study aimed to describe the clinical features, radiological biomarkers, treatments, and functional ...
Zeqiang Ji, Jianlong Zhang, Yiming Shi, Shiyu Shan, Yang Du, Guangshuo Li, Ying Jin, Yani Zhang, Chuanying Wang, Yijun Lin, Yuhao Guo, Decai Tian, Xingquan Zhao, Tian Song   +13 more
wiley   +1 more source

Low Incidence of Relapses After Vaccination in Anti‐Aquaporin‐4 Antibody‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Patients with neuromyelitis optica spectrum disorder (NMOSD) may experience increased signs and symptoms of their underlying disease when vaccinated against meningococcal disease before receiving complement component 5 inhibitor therapies. This retrospective analysis indicated an overall low relapse incidence (mean [range], 3.3% [0.7%–10.6 ...
Sean J. Pittock, Jin Nakahara, Becky Parks, Kerstin Allen, Sami Fam   +4 more
wiley   +1 more source